“Any company could not be in their right mind if they wanted to invest $150 [million] to $200 million to run through clinical trials and get FDA registration for the sale of a EEE vaccine,” Tuft University's Sam Telford says.
↧
“Any company could not be in their right mind if they wanted to invest $150 [million] to $200 million to run through clinical trials and get FDA registration for the sale of a EEE vaccine,” Tuft University's Sam Telford says.